期刊文献+

Barrett食管病理分型 组织异型性与环氧合酶2及幽门螺杆菌感染的相关性研究 被引量:3

在线阅读 下载PDF
导出
摘要 目的探讨食管腺癌前期(BE)患者食管病理分型、组织异型性与环氧合酶2(COX.2)及幽门螺杆菌(HP)感染的关系。方法采用免疫组化法及14C-尿素呼气试验检测137例BE患者及134例健康者食管中COX-2和HP感染的表达情况。结果COX-2在BE中高表达,而在正常组织中无表达或弱表达,COX-2表达与BE病理类型及组织异型性,差异有统计学意义(P〈0.01);HP感染率在BE及正常组织中表达差异无统计学意义(P〉0.05),与BE病理类型及组织异型性差异无统计学意义(P〉0.05)。结论BE中COX.2的表达与BE的病理类型及组织异型性有关,提示COX-2表达与BE的发生发展有密切关系,而BE的发生与HP状态无关。 Objective To explore the correlations of pathological typing, tissue atypia and COX-2 and helicobacter pylori (HP) infection in the patients of Barrett esophagus(BE). Methods Immunohistochemisty and 14C-urea breath test were applied to measure the expression of COX-2 and HP infection in 137 patients of BE and 134 healthy people as control. Results The expression of COX-2 was high in BE while low or none in normal tissues, the expression of COX-2 was statistically different among different pathological types, tissue atypia of BE ( P〈0.01 ) , the difference of HP infection rates was not statistically different among different pathological types, tissue atypia of BE ( P〉0.05 ) . Conclusions The expression of COX-2 is statistically correlated to different pathological types, tissue atypia of BE,which implied that the COX-2 has a close relationship to the progression of BE while HP doesn't.
出处 《浙江临床医学》 2013年第3期330-332,共3页 Zhejiang Clinical Medical Journal
关键词 BARRETT食管 病理分型 组织异型性 环氧合酶2 幽门螺杆菌 Barrett esophagus Pathological typing Tissue atypia cyclooxygenase 2 Helicobacter pylori
  • 相关文献

参考文献9

  • 1Lagarde SM, tenKate FJ, Reitsma JB, et al.Prognostic factors in adenocareinoma of the esophagus or gastroesophageal junction.] Clin Onco1.2006, 24(26):4347-4355.
  • 2Pera M, Manterola C, Vidal 0, et al. Epidemiology of esophageal adenocarcinoma .J Surg Oncol, 2005, 92 (3) : 151-159.
  • 3van Rees B P, Ristirnaki A. Cyciooxygenase-2 in carcinogenesis of the gastrointestinal trac . Scand J Gastroenterol, 2001, 36 ( 9) :897-903.
  • 4van Rees B P, Saukkonen K, Rostimaki A, et al.Cyciooxygenase-2 expression during carcinogenesis in the human stomach J Pathol, 2002, 196( 2) : 171-179.
  • 5Hamoui N, Peters JH, Sehneider S, et al. Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase+ 2 gene expression in the squamous epithelium of the lower esophagus. Arch Surg, 2004, 139(7):712-716;discussion716-717.
  • 6Oyama K, Fujimura T, Ninomiya I, et al. Cyciooxygenase(COX)-2 expression in a rat duodenoesophageal reflux model and chemo?prevention of adenocarcinoma by t he selective COX-2 inhibitor nimesulide, Nihon Shokakibyo Gakkai Zasshi, 2007, 104(8): 1183-1191.
  • 7Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Nat! Cancer lust, 2004 , 96(5):388-396.
  • 8Ramus JR, Gatenby PA, Caygill CP, et al. Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus. Dig Dis Sci, 2007,52(10):2821-2825.
  • 9Jonaitis LV,Kiudelis G,Kupciuskas L.Characteristics of patients with erosive and nonerosive GERD in high-helicobacter-pylori prevalence region. Dis Esophagus 2004,17(3):223-227.

同被引文献34

  • 1张春容,杨天文.环氧合酶-2的表达与胃癌发生的关系及Hp感染对COX-2其表达的影响[J].中国老年学杂志,2014,34(1):68-69. 被引量:6
  • 2Hunt RH,Xiao SD,Megraud F,Leon-Barua R,Bazzoli F,Van der Merwe S,vaz Coelho LG,Fock KM,Fedail S,Cohen H,Malfertheiner P,Vakil N,Hamid S,Goh KL,Wong BC,Krabshuis JH,杜颖,丛衍群,戴宁.世界胃肠病学组织(WGO-OMGE)临床指南——发展中国家幽门螺杆菌感染[J].胃肠病学,2007,12(1):40-52. 被引量:85
  • 3Hirota WK,Loughney TM,Lazas DJ. Specialized intestinal metaplasia,dysplasia,and cancer of the esophagus and esophagogastric junction:prevalence and clinical data[J].Gastroenterology,1999,(02):277-285.
  • 4Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology.Updated guidelines for the diagnosis,surveillance,and therapy of Barrett' s esophagus[J].Am J Gastroenterol,2002,(08):1888-1895.
  • 5Liu FX,Wang WH,Wang J. Effect of Helicobacter pylori infection on Barrett' s esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux[J].Helicobacter,2011,(01):66-77.
  • 6Ramus JR,Gatenby PA,Caygill CP. Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus[J].Dig Dis Sci,2007,(10):2821-2825.
  • 7Ye W,Held M,Lagergren J. Helicobacter pylori infection and gastric atrophy:risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia[J].J Natl Cancer Inst,2004,(05):388-396.
  • 8Abe Y,Ohara S,Koike T. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan[J].Am J Gastroenterol,2004,(07):1213-1221.
  • 9Thrift AP,Pandeya N,Smith KJ. Helicobacter pylori infection and the risks of Barrett' s oesophagus:a population-based casecontrol study[J].Int J Cancer,2012,(10):2407-2416.
  • 10Csendes A,Smok G,Cerda G. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux,erosive esophagitis or Barrett' s esophagus[J].Dis Esophagus,1997,(01):38-42.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部